MTAP and neoplasm: In line with our data, these authors found MTAP deficiency in 22% of their patients, identified tumor‐adjacent dysplastic urothelium solely on the basis of unequivocal MTAP negativity in several cases, and found persistent MTAP deficiency in 37 of 38 subsequent recurrences [24].